{"nctId":"NCT02109640","briefTitle":"A Comparison of Targinact vs. Oxycodone on Gut Function After Colorectal Surgery","startDateStruct":{"date":"2014-10"},"conditions":["Postoperative Pain","Postoperative Nausea and Vomiting"],"count":50,"armGroups":[{"label":"Targinact","type":"EXPERIMENTAL","interventionNames":["Drug: Targinact","Procedure: Laparoscopic segmental colectomy"]},{"label":"Oxycodone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Oxycodone","Procedure: Laparoscopic segmental colectomy"]}],"interventions":[{"name":"Targinact","otherNames":["Oxycodone-Naloxone"]},{"name":"Oxycodone","otherNames":[]},{"name":"Laparoscopic segmental colectomy","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients scheduled for elective laparoscopic segmental colectomy at the Colorectal Surgery Unit, Western General Hospital, Edinburgh.\n\nExclusion Criteria:\n\n* Pregnancy Age \\<18 years Patients lacking capacity to give informed consent. Severe liver dysfunction (Child's A or greater) Patients participating in another therapeutic clinical trial Contraindication to oxycodone, naloxone or Targinact Pre-existing dependence on opioid analgesia (current medications will be checked prior to discussing consent) Pre-existing use of opioid analgesia for chronic pain (current medications will be checked prior to discussing consent) Patients with rectal cancer Plan to form any stoma during procedure","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Prevalence of Postoperative Gut Dysfunction","description":"The proportion of participants with gut dysfunction, defined as the presence of any of the following sufficient to delay discharge on the 3rd postoperative day: nausea, vomiting, intolerance of oral intake or constipation.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"15","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Opioid Analgesia Consumption","description":"Total dose of systemic and oral Oxycodone or Targinact taken in hospital or at home until discontinued by the participant","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"78","spread":"36"},{"groupId":"OG001","value":"94","spread":"56"}]}]}]},{"type":"SECONDARY","title":"Pain Scores","description":"Overall Benefit of Analgesia Score (OBAS): Score range 0-28 with low score=high benefit. Summed from subscales of 0-4 for the following questions:\n\n* Please rate your current pain at rest on a scale between 0⁄4 minimal pain and 4⁄4 maximum imaginable pain\n* Please grade any distress and bother from vomiting in the past 24 h (0⁄4 not at all to 4⁄4 very much)\n* Please grade any distress and bother from itching in the past 24 h (0⁄4 not at all to 4⁄4 very much)\n* Please grade any distress and bother from sweating in the past 24 h (0⁄4 not at all to 4⁄4 very much)\n* Please grade any distress and bother from freezing in the past 24 h (0⁄4 not at all to 4⁄4 very much)\n* Please grade any distress and bother from dizziness in the past 24 h (0⁄4 not at all to 4⁄4 very much)\n* How satisfied are you with your pain treatment during the past 24 h (0⁄4 not at all to 4⁄4 very much) Lehmann N. British Journal of Anaesthesia 105 (4): 511-18 (2010)","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":27},"commonTop":["Hypotension","Wound healing","Hypoxaemia postop","Acute urinary retention"]}}}